ALTANA AG:企業のM&A・事業提携・投資動向

◆英語タイトル:ALTANA AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C0813
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

ALTANA AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s ALTANA AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ALTANA AG since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes ALTANA AG’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by ALTANA AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on ALTANA AG’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by ALTANA AG and its subsidiaries since 2007.
- Information about key financial and legal advisors for ALTANA AG’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about ALTANA AG’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 50
Corporate Venturing – Overview 50
Corporate Venturing – Deal reports 51
PARTNERSHIP 53
Partnership – Deal reports 53
PRIVATE EQUITY & OWNERSHIP 59
Private Equity and Ownership – Deal reports 59
APPENDIX 62
Contact Us 62
About MarketLine Financial Deals Database 62
Deal Definition and Methodology 64
About MarketLine 71

List of Tables
Table 1: ALTANA AG M&A volume and value trend (2014-YTD2018)
Table 2: ALTANA AG M&A activity by geography (2014-YTD2018)
Table 3: ALTANA AG corporate venturing volume and value trend (2014-YTD2018)
Table 4: ALTANA AG corporate venturing by geography (2014-YTD2018)

List of Figures
Figure 1: ALTANA AG M&A volume and value trend (2014-YTD2018)
Figure 2: ALTANA AG M&A activity by geography (2014-YTD2018)
Figure 3: ALTANA AG corporate venturing volume and value trend (2014-YTD2018)
Figure 4: ALTANA AG corporate venturing by geography (2014-YTD2018)

★海外企業調査レポート[ALTANA AG:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DiaCarta Inc:企業の製品パイプライン分析2018
    Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection ki …
  • Grupo Aval Acciones Y Valores Sa:企業の戦略・SWOT・財務分析
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, infl …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • Sharp HealthCare:企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • PostNL NV (PNL):企業の財務・戦略的SWOT分析
    PostNL NV (PNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Syros Pharmaceuticals Inc (SYRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Ignyta Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • TrialBee AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TrialBee AB (TrialBee) is a provider of innovative software solutions that accelerates clinical trials. The company provides services such as online patient recruitment, online study feasibility, study retention and electronic data capture, among others. It offers cloud based solution which …
  • Travelzoo Inc.:企業の戦略・SWOT・財務情報
    Travelzoo Inc. - Strategy, SWOT and Corporate Finance Report Summary Travelzoo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Analog Devices Inc (ADI):企業の財務・戦略的SWOT分析
    Analog Devices Inc (ADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fomento de Construcciones y Contratas SA (FCC):企業の財務・戦略的SWOT分析
    Fomento de Construcciones y Contratas SA (FCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Cytox Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Instrumentation Laboratory Company-医療機器分野:企業M&A・提携分析
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides …
  • Siliconware Precision Industries Co., Ltd. (2325):企業の財務・戦略的SWOT分析
    Siliconware Precision Industries Co., Ltd. (2325) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆